The DAT1 gene codes for the dopamine transporter, which clears dopamine from the synaptic cleft, and a variant of this gene has previously been associated with compromised response inhibition in both healthy and clinical populations. This variant has also been associated with ADHD, a disorder that is characterised by disturbed dopamine function as well as problems with response inhibition. In the present study we used fMRI to investigate the role of dopaminergic genetic variation on executive functioning by comparing how activation associated with successful and unsuccessful inhibitions differs based on DAT1-genotype and ADHD-diagnosis in adolescents performing a go/nogo task. The results identify regional specificity concerning which functional differences can be attributed to the possession of the high risk DAT1 genotype, the clinical condition or an interaction between the two. During response inhibition, individuals with two copies of the 10-repeat allele showed increased activation in frontal, medial, and parietal regions, which may indicate that inhibition is more effortful for this group. Conversely, this group displayed a reduced error response in the parahippocampal gyrus, suggestive of reduced learning from errors. There were also a number of frontal, parietal, medial and occipital regions, where the relationship between genotype and fMRI-activation differed between the ADHD group and the typically developing adolescents. Finally, the ADHD group displayed decreased activation in parietal and (pre)frontal regions during response inhibition, and in frontal and medial brain regions on error trials.
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Introduction
Controlling and inhibiting actions are important cognitive abilities that allow us to function successfully in a changing and complex environment. Individual differences in executive functioning such as response inhibition and error monitoring have been related to genetic variation (Goldberg & Weinberger, 2004) , for example, by studying unaffected family members of clinical groups with deficits in response inhibition (Slaats-Willemse, Swaab-Barneveld, de Sonneville, van der Meulen, & Buitelaar, 2003) and by comparing groups who differ in genotype. Earlier studies suggest an important role for the dopamine system in response inhibition: typically * Corresponding author at: Laboratory of Experimental Psychology, University of Leuven, Tiensestraat 102, B 3000 Leuven, Belgium. Tel.: +32 0 16 32 59 57; fax: +32 0 16 32 60 99.
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developing children homozygous for the 10-repeat allele of DAT1 perform less well on a test of response inhibition (Cornish et al., 2005) , though this effect can be modulated by genotypic variation on other dopaminergic genes such as DRD4 (Congdon, Lesch, & Canli, 2007) . In this study we investigate the role of dopaminergic functioning in response inhibition and error-monitoring, by comparing the effects of variation in DAT1-genotype in typically developing adolescents and in adolescents diagnosed with ADHD.
Attention Deficit/Hyperactivity Disorder (ADHD) is a childhood disorder characterised by symptoms of inattention, hyperactivity and impulsivity (DSM-IV). The disorder is relatively common, with between 3 and 5% of school-age children affected (Buitelaar, 2002) . ADHD symptoms persist into adulthood in about 65% of cases (Faraone, Biederman, & Mick, 2006) and individuals with ADHD often show impairments of executive function, including the ability to control and inhibit behaviour (Nigg, 2005) .
ADHD is thought to have a strong genetic component, with additive effects of multiple genes explaining around 80% of an individual's susceptibility to ADHD (Albayrak, Friedel, Schimmelmann, 
